United States · Series B startup

Who invested in FreeWill

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Legaltech

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $30MMar 2022
Investors
5
See who backed them

The rounds

  1. Mar 2022
    Series B$30M

    Source recordedSEC filing: $30M sold, first sale Feb 2022

Everyone who backed them

QED InvestorsVC firm1round
Pear VCVC firm1round
Ulu VenturesVC firm1round
ICONIQ CapitalFamily office1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list FreeWill as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Dorm Room FundVC firmPer its own site
Iconiq CapitalGrowth equityPer its own site
ICONIQ CapitalFamily officePer its own site
National Kidney FoundationGovernmentPer its own site

Quick answers about FreeWill

Who invested in FreeWill?

FreeWill's investors include Highland Capital Partners, QED Investors, Pear VC, Ulu Ventures and ICONIQ Capital.

How much has FreeWill raised?

FreeWill has raised $30M across 1 round since 2022.

When did FreeWill last raise?

FreeWill's most recent round was a Series B of $30M in Mar 2022.

What was FreeWill's biggest round?

Its most recent round, $30M in Mar 2022, is also its largest on record.

Who backed FreeWill first?

FreeWill's first round on record, in Mar 2022, was backed by Highland Capital Partners, QED Investors and Pear VC and 2 others.

What stage is FreeWill at?

FreeWill's latest named round is a Series B, in Mar 2022.

Where is FreeWill based?

FreeWill is based in the United States.

Companies like FreeWill

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.